Congo strengthens efforts to contain mpox outbreaks despite challenges

Health authorities in the Democratic Republic of Congo are ramping up efforts to control outbreaks of mpox a zoonotic disease endemic to the region. Despite facing significant challenges, including conflict, displacement, and strained healthcare systems, Congo’s health sector has made strides in addressing the spread of the virus.

In recent months, the World Health Organization (WHO) declared outbreaks in Congo and other African nations a global health emergency. Of the 25,093 confirmed and suspected cases in Africa this year, Congo has recorded over 21,000, underscoring the scale of the challenge. However, international collaboration and a concerted local response are paving the way for progress.

Congo, which has dealt with mpox for decades, is now contending with a new, potentially more infectious strain that recently spread to South Kivu, a province in the country’s conflict-ridden east. Despite these difficulties, healthcare workers on the ground remain committed to their mission. “It’s truly a challenge,” said Dr. Musole Mulambamunva Robert, medical director of Kavumu hospital in eastern Congo, “but we are determined to treat every patient who comes to us.”

Also Read: Scientists make breakthrough in identifying first known rabies outbreak among seals in South Africa

The arrival of 250,000 mpox vaccines from the European Union and the United States offers hope, though Congolese authorities acknowledge the need for additional doses—around 3 million in total—to meet the country’s needs. The rollout, while still in its early stages, represents a critical step toward curbing the virus.

Public health experts emphasize that vaccines are just one part of the equation. Emmanuel Lampaert, Congo representative for Doctors Without Borders, highlighted the importance of grassroots health education campaigns, case identification, and patient isolation. “Vaccines are an additional tool, but community engagement and health interventions will ultimately determine our success,” he said.

While critics have noted that international interest and funding for mpox have lagged behind past responses to Ebola and COVID-19, there is optimism that heightened awareness and coordinated efforts can turn the tide. Collaborative work with organizations such as the International Federation of Red Cross and Red Crescent, alongside local health agencies, is making a positive impact on the ground.

In the face of adversity, Congo’s health authorities and global partners are making progress. The fight to contain mpox is ongoing, but with continued support and resource mobilization, there is hope for a brighter, healthier future in the region.